Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech
Wearable Devices (NASDAQ:WLDS) announced the expansion of its Large Motor Unit Action Potential Model (LMM) into predictive health monitoring and cognitive state analytics markets. The company's AI-powered bio-signal platform will enable real-time physiological monitoring for health and wellness conditions.
The expansion aligns with increasing federal interest in wearable health technology, as highlighted by U.S. Health Secretary Robert F. Kennedy Jr.'s recent advocacy. The LMM platform will focus on three key areas: predictive health monitoring, cognitive state analytics, and predictive analytics. Wearable Devices plans to make LMM available to enterprises, researchers, and developers for custom healthcare and sports applications.
Wearable Devices (NASDAQ:WLDS) ha annunciato l'espansione del suo Modello di Potenziale d'Azione dell'Unità Motoria Grande (LMM) nei mercati del monitoraggio sanitario predittivo e dell'analisi dello stato cognitivo. La piattaforma bio-segnale basata su intelligenza artificiale dell'azienda permetterà il monitoraggio fisiologico in tempo reale per condizioni di salute e benessere.
Questa espansione è in linea con il crescente interesse federale verso la tecnologia sanitaria indossabile, come evidenziato dalla recente promozione del Segretario alla Salute degli Stati Uniti, Robert F. Kennedy Jr. La piattaforma LMM si concentrerà su tre aree chiave: monitoraggio sanitario predittivo, analisi dello stato cognitivo e analisi predittiva. Wearable Devices intende rendere LMM disponibile per aziende, ricercatori e sviluppatori per applicazioni personalizzate nel settore sanitario e sportivo.
Wearable Devices (NASDAQ:WLDS) anunció la expansión de su Modelo de Potencial de Acción de Unidad Motora Grande (LMM) hacia los mercados de monitoreo predictivo de salud y análisis del estado cognitivo. La plataforma de bioseñales impulsada por IA de la compañía permitirá la monitorización fisiológica en tiempo real para condiciones de salud y bienestar.
La expansión se alinea con el creciente interés federal en la tecnología sanitaria portátil, como destacó recientemente el Secretario de Salud de EE.UU., Robert F. Kennedy Jr. La plataforma LMM se enfocará en tres áreas clave: monitoreo predictivo de salud, análisis del estado cognitivo y análisis predictivo. Wearable Devices planea ofrecer LMM a empresas, investigadores y desarrolladores para aplicaciones personalizadas en salud y deportes.
웨어러블 디바이스(Wearable Devices, NASDAQ:WLDS)는 대형 운동 단위 활동 전위 모델(LMM)을 예측 건강 모니터링 및 인지 상태 분석 시장으로 확장한다고 발표했습니다. 회사의 AI 기반 바이오 신호 플랫폼은 건강 및 웰빙 상태에 대한 실시간 생리학적 모니터링을 가능하게 할 것입니다.
이번 확장은 미국 보건부 장관 로버트 F. 케네디 주니어(Robert F. Kennedy Jr.)의 최근 지지를 포함한 연방 정부의 웨어러블 건강 기술에 대한 관심 증가와 맞물려 있습니다. LMM 플랫폼은 예측 건강 모니터링, 인지 상태 분석, 예측 분석의 세 가지 주요 분야에 집중할 예정입니다. 웨어러블 디바이스는 맞춤형 의료 및 스포츠 애플리케이션을 위해 기업, 연구자 및 개발자에게 LMM을 제공할 계획입니다.
Wearable Devices (NASDAQ:WLDS) a annoncé l'expansion de son Modèle de Potentiel d'Action des Grandes Unités Motrices (LMM) vers les marchés de la surveillance prédictive de la santé et de l'analyse de l'état cognitif. La plateforme de bio-signaux alimentée par l'IA de la société permettra une surveillance physiologique en temps réel pour les conditions de santé et de bien-être.
Cette expansion s'aligne avec l'intérêt croissant du gouvernement fédéral pour la technologie de santé portable, comme l'a récemment souligné le Secrétaire à la Santé des États-Unis, Robert F. Kennedy Jr. La plateforme LMM se concentrera sur trois domaines clés : surveillance prédictive de la santé, analyse de l'état cognitif et analyse prédictive. Wearable Devices prévoit de rendre le LMM disponible aux entreprises, chercheurs et développeurs pour des applications personnalisées dans les domaines de la santé et du sport.
Wearable Devices (NASDAQ:WLDS) gab die Erweiterung seines Large Motor Unit Action Potential Modells (LMM) auf die Märkte für prädiktive Gesundheitsüberwachung und kognitive Zustandsanalysen bekannt. Die KI-gestützte Bio-Signal-Plattform des Unternehmens ermöglicht die Echtzeit-physiologische Überwachung von Gesundheits- und Wellnesszuständen.
Die Erweiterung steht im Einklang mit dem zunehmenden bundesstaatlichen Interesse an tragbarer Gesundheitstechnologie, wie kürzlich vom US-Gesundheitsminister Robert F. Kennedy Jr. betont wurde. Die LMM-Plattform wird sich auf drei Hauptbereiche konzentrieren: prädiktive Gesundheitsüberwachung, kognitive Zustandsanalysen und prädiktive Analysen. Wearable Devices plant, LMM Unternehmen, Forschern und Entwicklern für maßgeschneiderte Gesundheits- und Sportanwendungen zur Verfügung zu stellen.
- Expansion into new markets with predictive health monitoring and cognitive analytics applications
- Strategic alignment with federal government's interest in wearable health technology
- Platform will be made available to enterprises, researchers, and developers for custom applications
- Technology offers potential for early detection of health conditions through AI-driven analysis
- Technology is still in evaluation phase in controlled environments
- Commercialization timeline and partnership details not yet specified
- No concrete revenue projections or market size estimates provided
Insights
Wearable Devices expands its AI platform into health monitoring, aligning with government interest, but remains in early evaluation phase.
Wearable Devices is strategically expanding its Large Motor Unit Action Potential Model (LMM) beyond its original gesture-control applications into predictive health monitoring and cognitive state analytics. This represents a significant pivot that could open substantial new market opportunities in healthcare and wellness.
The company's technology differentiates itself through continuous learning capabilities that transform passive wrist-based muscle activity data into actionable health insights. What's particularly noteworthy is the timing of this expansion, which aligns with increased government interest in wearable health technologies, as evidenced by the mention of HHS Secretary Robert F. Kennedy Jr.'s advocacy.
However, investors should recognize that the technology remains in an evaluation phase in controlled environments. The press release uses language like "being evaluated" and "intending to make LMM available," indicating the commercialization timeline is still uncertain. The company hasn't provided specific metrics on testing results, partnerships, or revenue projections from this expansion.
The planned business model appears to involve platform licensing to enterprises, researchers, and developers rather than direct-to-consumer sales. This B2B approach could potentially create more sustainable revenue streams if successful, but will require significant partnership development.
While the health monitoring wearables market is growing rapidly, Wearable Devices will face intense competition from established players. The press release lacks details on regulatory approvals, which will be necessary for health applications, and doesn't specify what health conditions the technology might be capable of monitoring.
Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, recently announced the expansion of its Large Motor Unit Action Potential Model (“LMM”) into new potential markets, such as predictive health monitoring and cognitive state analytics. This development will enable the broadening of bio-signal intelligence applications beyond wearables and will offer businesses and healthcare providers access to real-time physiological insights for monitoring health and wellness conditions.
This strategic expansion into predictive health monitoring aligns with the rising interest in personalized wellness devices. This interest is now demonstrated at the federal level. U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., has recently advocated for wearable devices to enhance health monitoring and cognitive well-being, underscoring the public and institutional momentum toward real-time data-driven care.
This announcement follows Wearable Devices’ recent introduction of LMM as a groundbreaking AI-driven bio-signal platform focused on gesture-based control in extended reality (“XR”) and neural interaction with digital devices. The Company’s LMM approach to analyzing muscle activity signals will support the expansion into the field of health monitoring, enabling users to enhance their performance across various domains.
From Passive Monitoring to Proactive Intelligence
Unlike traditional bio-sensors that collect data passively, LMM continuously learns and adapts, turning muscle activity signals from the wrist into actionable insights. The technology is now being evaluated in controlled environments for real-world applications, including:
| ● | Predictive Health Monitoring - Detecting hidden patterns in muscle activity that may indicate early signs of health conditions before symptoms appear, revolutionizing preventive diagnostics and digital health tracking. | |
| ● | Cognitive State & Performance Analytics - Monitoring focus, fatigue, and stress levels through muscle tone and micro-movements, optimizing work productivity and mental well-being. | |
| ● | Exploring Predictive Analytics - Assessing whether continuous monitoring of neural data can improve AI-driven user behavior predictions. |
A Platform for Innovation: Opening LMM to Business Partners
Recognizing the transformative potential of bio-signal intelligence, Wearable Devices is intending to make LMM available to enterprises, researchers, and developers. The Company’s AI-powered bio-signal data platform is expected to enable businesses to:
| ● | Develop custom applications tailored to healthcare and sports for athletic performance optimization. | |
| ● | Integrate real-time physiological insights into enterprise solutions to enhance safety, performance, and productivity. | |
| ● | Leverage LMM’s AI engine to continuously refine predictive health and interaction models. |
Following the initial evaluation phase, Wearable Devices aims to accelerate commercialization and strategic partnerships across the health sector, reinforcing its position as a pioneer in bio-signal intelligence and neural interface technology.
About Wearable Devices Ltd.
Wearable Devices Ltd. is a pioneering growth company revolutionizing human-computer interaction through its AI-powered neural input technology for both consumer and business markets. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s innovative products, including the Mudra Band for iOS and Mudra Link for Android, enable seamless, touch-free interaction by transforming subtle finger and wrist movements into intuitive controls. These groundbreaking solutions enhance gaming, and the rapidly expanding AR/VR/XR landscapes. The Company offers a dual-channel business model: direct-to-consumer sales and enterprise licensing. Its flagship Mudra Band integrates functional and stylish design with cutting-edge AI to empower consumers, while its enterprise solutions provide businesses with the tools to deliver immersive and interactive experiences. By setting the input standard for the XR market, Wearable Devices is redefining user experiences and driving innovation in one of the fastest-growing tech sectors. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq under the symbols “WLDS” and “WLDSW,” respectively.
Forward-Looking Statements Disclaimer
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when we discuss the benefits and advantages of our devices and technology, including the potential of LMMs, the potential to accelerate commercialization and strategic partnerships across the health sector, the rising interest in personalized wellness devices and entering markets that need real-time physiological insights. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2024, filed on March 20, 2025 and our other filings with the SEC. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Investor Relations Contact
Michal Efraty
IR@wearabledevices.co.il
FAQ
What new markets is Wearable Devices (WLDS) expanding into with its LMM technology?
How does Wearable Devices' LMM technology differ from traditional bio-sensors?
What are the main applications of WLDS's LMM platform in health monitoring?
How is Wearable Devices planning to commercialize its LMM platform?
What is the significance of the U.S. HHS Secretary's support for WLDS's technology?
